No Symptoms After Heart Surgery Isn't No Risk | Healos™
No Symptoms Does Not Mean No Risk: Why Stability Is the Most Critical Window
There's a particular kind of relief that arrives about six months after a heart attack or stent. The fatigue has lifted. The follow-up appointments are further apart. You've stopped listening to your own heartbeat at night. Friends say you look like yourself again, and you agree.
Enjoy that. It's earned. But it is also the moment when the most important part of long-term recovery quietly begins, because the absence of symptoms and the absence of risk are two very different things.
Here is the short answer. Feeling well 6 to 18 months after a heart attack or stent is good news, but it doesn't mean risk is gone. About 1 in 5 survivors has another major cardiovascular event in the first year, and risk stays elevated for years. Many heart attacks cause no clear symptoms, and adherence to protective medications often slips once people feel fine.
简短的答案： 心梗或支架后大约半年，一种特别的轻松感会到来：疲劳消退，复诊间隔拉长，夜里不再听自己的心跳，朋友说你又像原来的自己了。好好享受，这是你挣来的。但这也是长期康复中最重要的部分悄悄开始的时刻，因为「没有症状」和「没有风险」是两回事。
感觉良好是好消息，但约五分之一的幸存者在第一年内再次发生主要心血管事件，风险在之后数年仍然偏高；很多心梗没有明显症状，而人们一旦感觉良好，保护性药物的依从性往往下滑。
Can you have another heart attack without symptoms?
Yes, and more often than most people realise. In the long-running ARIC study, about 45% of heart attacks were silent: they caused no symptoms clear enough to send the person to hospital and were discovered only on a later ECG (Zhang et al., Circulation, 2016). Silent heart attacks still damage heart muscle and still raise the risk of future events.
The same logic applies to the processes that lead to a heart attack. Plaque growth, rising blood pressure, creeping LDL cholesterol and chronic inflammation make no noise. As the 10-year cellular timeline shows, atherosclerosis spends most of its life completely silent. Feeling good tells you that your heart is coping well today. It can't tell you what's happening in your arteries.
没有症状也会再发心梗吗： 会，而且比大多数人想象的更常见。长期 ARIC 研究中约 45% 的心梗是「无症状」的：症状不足以让人去医院，直到后来做心电图才被发现（Circulation 2016），它们同样损伤心肌、增加未来风险。
导致心梗的过程也一样：斑块生长、血压上升、LDL 慢慢升高、慢性炎症都悄无声息。感觉良好说明心脏今天应对得不错，却无法告诉你动脉里正在发生什么。
What is the risk of another heart attack after the first year?
The best real-world picture comes from a Swedish national registry of more than 97,000 heart attack survivors. In the first year, about 18% had another heart attack, a stroke or cardiovascular death. The finding that surprises people is what came next: among those who made it through the first year without any event, about 20% had one over the following three years (Jernberg et al., European Heart Journal, 2015).
In other words, getting through year one safely is a real achievement, but it doesn't reset your risk to that of someone who never had heart disease. The risk curve flattens; it doesn't disappear. That is why cardiologists talk about lifelong secondary care, and why the stable phase deserves as much structure as the months right after the procedure.
第一年之后再发心梗的风险： 最好的真实世界数据来自瑞典全国登记的 9.7 万多名心梗幸存者：第一年约 18% 再次发生心梗、卒中或心血管死亡。令人意外的是：第一年平安度过的人中，约 20% 在随后三年内发生事件（欧洲心脏杂志 2015）。
也就是说，平安度过第一年是真正的成就，但并不会把风险重置为从未得过心脏病的人。风险曲线变平了，却没有消失——这就是心脏科医生说「终身二级管理」的原因，也是稳定期需要与术后初期同等结构化的原因。
Why the stable phase is when people drift
Here's the uncomfortable part. The months when people feel best are often the months when protective habits quietly erode.
Medication adherence is the clearest example. When researchers followed older adults in Ontario after an acute coronary syndrome, only about 40% were still taking their statin two years later (Jackevicius et al., JAMA, 2002). Few of those people made a deliberate decision to stop. Prescriptions ran out and weren't renewed. A side effect was blamed on the pill. The pill stopped feeling necessary because nothing hurt.
Other habits follow the same curve. The daily walk becomes three times a week, then weekends. Salt creeps back. Appointments are spaced further apart, so there are fewer moments when anyone checks. Psychologists sometimes call this a false sense of safety: the brain reads "no symptoms" as "problem solved".
None of this is a character flaw. It is exactly what you'd expect when the reward for effort is invisible. Something that doesn't hurt is hard to keep treating unless you have a way to see that it still matters.
为什么稳定期最容易松懈： 令人不安的是：感觉最好的几个月，往往也是保护性习惯悄悄瓦解的几个月。
最典型的是服药依从性：安大略省老年人急性冠脉综合征后两年，只有约 40% 仍在服用他汀（JAMA 2002）。很少有人是刻意停药的——处方用完没续、把某个不适归咎于药、什么都不疼就觉得药没必要了。
其他习惯也一样：每天散步变成每周三次再变成只有周末，盐慢慢加回来，复诊间隔拉长，被人检查的机会变少。心理学上称之为「虚假的安全感」：大脑把「没有症状」理解成「问题已解决」。
这不是性格缺陷，而是努力的回报看不见时的必然结果——不疼的东西，除非能看到它依然重要，否则很难坚持管理。
The risk markers you can't feel, and how to track them
If symptoms aren't a reliable guide, what is? A handful of measurable markers give a far better picture of how your arteries are doing. Most are routine; a few are worth asking about.
LDL cholesterol. The single most important number for most people after a heart attack. Canadian guidelines use 1.8 mmol/L as the threshold for intensifying treatment after a heart attack (Pearson et al., Canadian Journal of Cardiology, 2021).
Blood pressure. Home readings, taken correctly and regularly, are more informative than an occasional clinic measurement.
hs-CRP. High-sensitivity C-reactive protein reflects low-grade inflammation. Inflammation carries its own risk: in the CANTOS trial, lowering it without changing cholesterol reduced repeat events by about 15% (Ridker et al., NEJM, 2017).
Lipoprotein(a). A largely inherited cholesterol particle that raises risk even when LDL is controlled. Canadian guidelines recommend measuring it once in adulthood. Many heart attack survivors have never had it checked.
Blood sugar, kidney function and waist size. Each shifts slowly and each changes your risk.
Mood and sleep. Depression and poor sleep are linked to worse outcomes and to slipping adherence. They are risk markers too, even though no blood test shows them.
Tracking these over time turns an invisible process into something you and your cardiologist can actually see and act on.
感觉不到的风险指标，以及如何追踪： 既然症状不可靠，什么才可靠？几项可测量的指标能更好地反映动脉状况。
LDL 胆固醇：多数心梗后患者最重要的数字，加拿大指南以 1.8 mmol/L 作为心梗后强化治疗的界值。
血压：正确、规律的家庭测量比偶尔的诊室读数更有信息量。
hs-CRP：反映低度炎症，CANTOS 试验中不改变胆固醇、仅降低炎症就使再发事件减少约 15%。
脂蛋白(a)：主要由遗传决定，即使 LDL 达标也会增加风险，加拿大指南建议成年后测一次，很多心梗幸存者从未测过。
血糖、肾功能和腰围：变化缓慢，但都会改变风险。
情绪与睡眠：抑郁和睡眠差与预后更差、依从性下滑相关，虽然没有血液检查能显示，但同样是风险指标。
长期追踪这些指标，能把看不见的过程变成你和医生都能看到、能行动的东西。
Repairing versus protecting: why this phase needs a different approach
The first months after a cardiac event are about repair: settling inflammation, rebuilding strength, adjusting medications, restoring nutrients that surgery and new prescriptions disturbed. That work has a beginning and an end.
The stable phase is different. The goal isn't to fix something that just happened; it's to keep the same conditions from slowly rebuilding. That calls for lower-intensity, longer-term support: steady maintenance nutrition matched to your medications, regular check-ins that make hidden markers visible, and a structure that keeps habits from drifting when nothing hurts.
That is what Sovereign Monthly · Protect is designed for. It provides monthly maintenance nutrition built around four cellular nutrients, adjusted to your diagnosis and medication list and pharmacist-reviewed before every kit ships, with regular check-ins that keep your numbers, sleep and habits in view and produce a summary for your cardiologist. It is complementary support alongside your medications and specialist follow-up, never a replacement for them, and it can be cancelled at any time.
修复与守护：为什么这一阶段需要不同的方法： 心脏事件后的头几个月重在修复：平息炎症、重建体力、调整药物、补回手术和新处方扰动的营养素，这项工作有始有终。稳定期不同：目标不是修复刚发生的事，而是防止同样的条件慢慢重新累积。这需要强度更低、周期更长的支持：与用药匹配的稳定维护营养、让隐藏指标变得可见的定期评估，以及在什么都不疼时防止习惯松懈的结构。
这正是 Sovereign Monthly · Protect 的设计目的：每月提供以四种细胞级营养素为核心、按诊断和用药调整、发货前经药剂师审核的维护营养，并定期评估各项数字、睡眠和习惯，生成给心脏科医生的摘要。它是与药物和专科随访并行的辅助支持，绝不替代，并可随时取消。
Between fear and complacency: finding the right level of attention
There are two ways to get the stable phase wrong, and they pull in opposite directions.
The first is complacency: treating the heart attack as a closed chapter, letting medications lapse and assuming that feeling fine means being fine. The second is fear: checking your pulse constantly, avoiding exercise, reading every twinge as the start of another event. Fear is exhausting, and it backfires. People who are frightened often move less, sleep worse and find it harder to stick with routines, which quietly raises the very risk they're worried about.
The healthy middle is structured attention. You don't need to think about your heart every hour. You need a small number of regular checkpoints that tell you, reliably, whether things are on track: a monthly review of mood, sleep and activity, lab results at the intervals your team recommends, and a clear plan for which symptoms mean "call today" and which mean "mention it at the next visit".
That structure does something important psychologically. It moves the job of worrying from you to the system. When the checkpoints look good, you can genuinely relax, because you have evidence rather than hope. When something shifts, it gets caught early, while it's still easy to address.
Families play a role here too. Partners often swing between the same two extremes, either hovering or assuming the danger has passed. Sharing the checkpoints with them gives everyone the same, calmer picture of how things are going.
在恐惧与松懈之间：找到合适的关注度： 稳定期有两种错误方式，方向相反。一种是松懈：把心梗当作翻过的一页，让药物中断，认为感觉好就是真的好。另一种是恐惧：不停摸脉搏、回避运动、把每一次不适都当成再次发病的开始——恐惧令人精疲力竭，而且适得其反：害怕的人往往活动更少、睡得更差、更难坚持规律，反而悄悄提高了他们担心的风险。
健康的中间状态是「结构化关注」：不需要每小时想着心脏，只需要少量定期检查点——每月回顾情绪、睡眠和活动，按医疗团队建议的间隔化验，并清楚哪些症状要「今天就打电话」、哪些可以「下次复诊再说」。
这种结构在心理上很重要：它把担心的工作从你身上转交给系统；检查点良好时，你可以真正放松，因为你有证据而不只是希望；一旦有变化，也能在容易处理时及早发现。
家属也一样常在两个极端间摇摆，与他们分享检查点，能让全家对进展有同样、更平静的认识。
Your stability checklist: six things to keep doing when you feel fine
Keep taking every prescribed medication, and renew prescriptions before they run out. If a side effect bothers you, talk to your doctor or pharmacist about alternatives rather than stopping.
Know your numbers: LDL, blood pressure, blood sugar and kidney function, and ask about hs-CRP and a one-time lipoprotein(a) test.
Protect your daily movement with a fixed time and a minimum you never skip, even on bad days.
Keep appointments even when you feel well. Those are the visits where silent changes get caught.
Check in on mood and sleep at least monthly, and tell your team if either slips.
Know the warning signs and call 911 for chest pain or pressure, new breathlessness, fainting or any sign of stroke, even if you've felt fine for months.
稳定期清单：感觉良好时仍要坚持的六件事：
① 坚持服用所有处方药，处方用完前续开；有副作用请与医生或药剂师讨论替代方案，而不是自行停药。
② 了解自己的数字：LDL、血压、血糖、肾功能，并询问 hs-CRP 和一次性脂蛋白(a)检测。
③ 守住每日活动：固定时间，设一个即使状态差也不跳过的最低量。
④ 感觉良好也按时复诊，无声的变化正是在这些复诊中被发现。
⑤ 至少每月关注一次情绪和睡眠，任何一项下滑都告诉医疗团队。
⑥ 记住警示信号：胸痛胸闷、新发气短、晕厥或任何卒中征兆，即使已经好几个月感觉良好，也请立即拨打 911。
The bottom line
Feeling fine after a heart attack or stent is the reward for everything you did in the first months. Protecting that feeling is the work of the next years. Risk after a cardiac event flattens but doesn't vanish, and it rarely announces itself. The people who do best are the ones who keep a quiet structure in place long after the symptoms are gone.
结论： 心梗或支架后感觉良好，是你在头几个月所有努力的回报；守住这种感觉，是接下来几年的功课。心脏事件后的风险会变平，但不会消失，而且很少提前打招呼。恢复最好的人，是那些在症状消失很久之后，仍保持一套安静结构的人。
Frequently asked questions
I feel fine after my heart attack. Do I still need to worry about my risk? Feeling well is a good sign, but risk remains elevated for years. In a Swedish registry, about 18% of survivors had another major cardiovascular event in the first year, and about 20% of those who were event-free after year one had an event in the following three years. Continuing medications and follow-up matters even when you feel fine.
Can you have a heart attack without symptoms? Yes. In the ARIC study, about 45% of heart attacks were silent and were discovered only on a later ECG. Silent heart attacks still damage heart muscle and raise future risk.
Why do people stop taking statins after a heart attack? Often without deciding to: prescriptions lapse, side effects are blamed on the medication, or it stops feeling necessary once there are no symptoms. In Ontario, only about 40% of older adults were still taking a statin two years after an acute coronary syndrome. Talk to your doctor before stopping any medication.
What tests should I have a year after a stent or heart attack? Common checks include LDL cholesterol, blood pressure, blood sugar and kidney function. It is also reasonable to ask about hs-CRP, a marker of inflammation, and a one-time lipoprotein(a) test, which Canadian guidelines recommend once in adulthood.
What is the difference between cardiac repair and long-term protection? Repair focuses on the months right after a cardiac event: settling inflammation, rebuilding strength and adjusting medications. Long-term protection focuses on keeping risk factors from slowly rebuilding through steady habits, maintenance nutrition matched to medications, and regular tracking of risk markers.
常见问题：
心梗后感觉很好，还需要担心风险吗？感觉良好是好迹象，但风险会在数年内保持偏高：瑞典登记中第一年约 18% 再发主要事件，第一年平安者中约 20% 在随后三年发生事件，即使感觉良好也要坚持用药和随访。
没有症状也会心梗吗？会，ARIC 研究中约 45% 的心梗是无症状的。
为什么很多人心梗后停用他汀？往往不是刻意的：处方中断、把不适归咎于药、没有症状就觉得没必要；安大略老年人两年后只有约 40% 仍在服用，停药前请咨询医生。
支架或心梗一年后该做哪些检查？LDL、血压、血糖、肾功能，也可询问 hs-CRP 和一次性脂蛋白(a)检测。
修复和长期守护有何不同？修复关注事件后头几个月；长期守护关注通过稳定习惯、与用药匹配的维护营养和定期追踪风险指标，防止风险因素慢慢重建。
References
Jernberg T, et al. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. European Heart Journal. 2015;36(19):1163–1170.
Zhang ZM, et al. Race and sex differences in the incidence and prognostic significance of silent myocardial infarction in the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2016;133(22):2141–2148.
Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–467.
Ridker PM, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS). New England Journal of Medicine. 2017;377:1119–1131.
Pearson GJ, et al. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia. Canadian Journal of Cardiology. 2021;37(8):1129–1150.
Lichtman JH, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome. Circulation. 2014;129(12):1350–1369.
